In vivo is on twitter

Partnership with Republic of Innovation
Follow us

We prefer #Friday. Why? Because of the #optimism bias! Discover why our #brain sees the glass half full.

RT @Confprof: Congress Chair of ESPACOMP on national radio interview … @CHUVLausanne @invivo_CHUV @MyLausanne @MySwi…

Mymetics announces new collaboration to advance the development of an innovative Malaria vaccine candidate -

Google wants to store your genome! -

Contrôler les gènes par la pensée! -

Exposition LAB/LIFE: Rencontres avec les chercheurs -

Philae a pu «renifler» des molécules organiques -

Givaudan ouvre un centre à Dubai -

Pilule amère, Alexion quitte Lausanne -

Mens Sana / Décryptage

The Science of Optimism

Cursus / Portrait

“Innovation is our greatest value"

Corpore Sano / Décryptage

The challenges of old age

Corpore Sano / Prospection

DNA does not tell everything

Mens Sana / Interview

“I’m con-cerned about the price”

Corpore Sano / Décryptage

Protons versus cancer

Cursus / Tandem

The Swiss Cancer Center, Lausanne

Focus / Editorial

A weight gene

Corpore Sano / Prospection

Botox: new relief for migraine sufferers

Focus / Editorial

Pleasure comes slow-cooked

In Situ / Et ailleurs

Hand-held doctor

In Situ / Health Valley

Developing the ecosystem… grounding our companies

Mens Sana / Innovation

Remote-controlled medicine

Focus / Editorial

Staying fit through healthy eating

Our favourite Twitter feeds